Akoya to Report Third Quarter 2022 Financial Results on November 7th, 2022

Rhea-AI Summary

Akoya Biosciences, Inc. (Nasdaq: AKYA) will announce its Q3 2022 financial results on November 7, 2022, after market close. Following the announcement, management will host a conference call at 5:00 p.m. ET to discuss the results. Interested investors are encouraged to register in advance for the call. Akoya specializes in spatial biology, offering innovative solutions for single-cell imaging and spatial phenotyping, aimed at enhancing understanding of biology and health.

Positive

• Specializes in spatial biology with innovative imaging solutions.
• Plans to provide Q3 2022 financial results, enhancing transparency.

Negative

• None.

MARLBOROUGH, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company^®, today announced that it will release financial results for the third quarter of 2022 after the market close on Monday, November 7^th, 2022. Company management will host a conference call to discuss financial results at 5:00 p.m. ET.

Investors interested in listening to the conference call are required to register online. It is recommended to register at least a day in advance. A live and archived webcast of the event will be available on the “Investors” section of the Akoya website at https://investors.akoyabio.com/.

About Akoya Biosciences
As The Spatial Biology Company^®, Akoya Biosciences’ mission is to bring context to the world of biology and human health through the power of spatial phenotyping. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. Akoya offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research via its key platforms: PhenoCycler™, PhenoImager™ Fusion and PhenoImager HT. To learn more about Akoya, visit www.akoyabio.com.

Investor Contact:
Priyam Shah
Sr. Director, Investor Relations
Akoya Biosciences, Inc.
investors@akoyabio.com

Media Contact:
Christine Quern
(617) 650-8497
media@akoyabio.com

FAQ

When will Akoya Biosciences release its Q3 2022 financial results?

Akoya Biosciences will release its Q3 2022 financial results on November 7, 2022.

What time is Akoya's conference call for Q3 2022 results?

The conference call will be held at 5:00 p.m. ET on November 7, 2022.

How can investors access Akoya's conference call?

Investors can register online to access the conference call and should register at least a day in advance.

What is Akoya's focus as a company?

Akoya focuses on spatial biology, providing solutions for single-cell imaging and spatial phenotyping.